SK281258B6 - (s)-alfa-2-pyridínetánamín, farmaceutická kompozícia s jeho obsahom a jeho použitie - Google Patents

(s)-alfa-2-pyridínetánamín, farmaceutická kompozícia s jeho obsahom a jeho použitie Download PDF

Info

Publication number: SK281258B6
Authority: SK; Slovakia
Prior art keywords: phenyl; pyridineethanamine; pharmaceutically acceptable; dose; compound
Prior art date: 1992-04-03

Application number

SK1177-94A

Other languages

English (en)

Slovak (sk)

Other versions

SK117794A3 (en

Inventor

Ronald Conrad Griffith

Robert John Murray

Michael Balestra

Original Assignee

Astra Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-04-03

Filing date

1993-04-01

Publication date

2001-01-18

1992-04-03 Priority claimed from GB929207339A external-priority patent/GB9207339D0/en

1992-04-15 Priority claimed from GB929208290A external-priority patent/GB9208290D0/en

1993-04-01 Application filed by Astra Ab filed Critical Astra Ab

1995-05-10 Publication of SK117794A3 publication Critical patent/SK117794A3/sk

2001-01-18 Publication of SK281258B6 publication Critical patent/SK281258B6/sk

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A61P25/10—Antiepileptics; Anticonvulsants for petit-mal
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A61P25/12—Antiepileptics; Anticonvulsants for grand-mal
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
Neurology (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Neurosurgery (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Biomedical Technology (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Pain & Pain Management (AREA)
Psychiatry (AREA)
Psychology (AREA)
Hospice & Palliative Care (AREA)
Epidemiology (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Pyridine Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Steroid Compounds (AREA)

SK1177-94A 1992-04-03 1993-04-01 (s)-alfa-2-pyridínetánamín, farmaceutická kompozícia s jeho obsahom a jeho použitie SK281258B6 (sk)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
GB929207339A GB9207339D0 (en)	1992-04-03	1992-04-03	Pharmaceutical compound
GB929208290A GB9208290D0 (en)	1992-04-15	1992-04-15	Pharmaceutical compound having neuroprotective properties
PCT/GB1993/000689 WO1993020052A1 (en)	1992-04-03	1993-04-01	Enantiomeric 1-phenyl-2-(2-pyridinyl)ethylamine for the treatment of neurodegenerative disorders

Publications (2)

Publication Number	Publication Date
SK117794A3 SK117794A3 (en)	1995-05-10
SK281258B6 true SK281258B6 (sk)	2001-01-18

Family

ID=26300643

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SK1177-94A SK281258B6 (sk)	1992-04-03	1993-04-01	(s)-alfa-2-pyridínetánamín, farmaceutická kompozícia s jeho obsahom a jeho použitie

Country Status (29)

Country	Link
EP (1)	EP0633879B1 (zh)
JP (2)	JP3120810B2 (zh)
KR (1)	KR100259567B1 (zh)
CN (1)	CN1044367C (zh)
AT (1)	ATE163925T1 (zh)
AU (2)	AU3897693A (zh)
CA (1)	CA2133427C (zh)
CZ (1)	CZ288519B6 (zh)
DE (1)	DE69317411T2 (zh)
DK (1)	DK0633879T3 (zh)
DZ (1)	DZ1677A1 (zh)
ES (1)	ES2115055T3 (zh)
FI (1)	FI105025B (zh)
HK (1)	HK1009331A1 (zh)
HU (1)	HU211529A9 (zh)
IL (1)	IL105276A (zh)
MA (1)	MA22866A1 (zh)
MX (1)	MX9301935A (zh)
MY (1)	MY110149A (zh)
NO (1)	NO302170B1 (zh)
NZ (1)	NZ251384A (zh)
PL (1)	PL180014B1 (zh)
RU (1)	RU2128650C1 (zh)
SG (1)	SG47948A1 (zh)
SK (1)	SK281258B6 (zh)
TW (1)	TW282455B (zh)
UA (1)	UA29437C2 (zh)
WO (1)	WO1993020052A1 (zh)
ZA (1)	ZA932415B (zh)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9320273D0 (en) *	1993-04-01	1993-11-17	Fisons Corp	Compound useful in therapy
DE68925933T2 (de) *	1988-08-12	1996-08-14	Fisons Corp	Arylalkylamine und -amide mit krampflösender und nervenschützender Wirkung
ZA942140B (en) *	1993-04-01	1994-10-03	Fisons Corp	Salt of (S)-alpha-phenyl-2-pyridineethanamine useful in therapy
SE9901077D0 (sv) *	1999-03-23	1999-03-23	Astra Ab	Novel use
SE9901237D0 (sv) *	1999-04-06	1999-04-06	Astra Ab	Novel use
SE9901340D0 (sv)	1999-04-15	1999-04-15	Astra Pharma Prod	Novel process
WO2007017652A2 (en) *	2005-08-10	2007-02-15	Astrazeneca Ab	Arylakylamines for the treatment of cancer
JP5491524B2 (ja) *	2008-12-24	2014-05-14	アストラゼネカ・アクチエボラーグ	エタンアミン化合物及びうつ病を処置するためのその使用
JP2015501652A (ja)	2011-12-14	2015-01-19	アストラゼネカ・アクチエボラーグＡｓｔｒａｚｅｎｅｃａＡｋｔｉｅｂｏｌａｇ	Ｇａｂｒ−ａ２診断
KR102469167B1 (ko) *	2013-11-05	2022-11-22	아스트라제네카 아베	Nmda 길항제 전구약물
CN115836052A (zh) *	2020-06-23	2023-03-21	拜尔哈文制药股份有限公司	(1s)-1-苯基-2-吡啶-2-基乙胺的局部制剂

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE68925933T2 (de) *	1988-08-12	1996-08-14	Fisons Corp	Arylalkylamine und -amide mit krampflösender und nervenschützender Wirkung

1993
- 1993-04-01 EP EP93907975A patent/EP0633879B1/en not_active Expired - Lifetime
- 1993-04-01 AT AT93907975T patent/ATE163925T1/de active
- 1993-04-01 DE DE69317411T patent/DE69317411T2/de not_active Expired - Lifetime
- 1993-04-01 NZ NZ251384A patent/NZ251384A/en not_active IP Right Cessation
- 1993-04-01 WO PCT/GB1993/000689 patent/WO1993020052A1/en active IP Right Grant
- 1993-04-01 CZ CZ19942409A patent/CZ288519B6/cs not_active IP Right Cessation
- 1993-04-01 CA CA002133427A patent/CA2133427C/en not_active Expired - Lifetime
- 1993-04-01 AU AU38976/93A patent/AU3897693A/en not_active Abandoned
- 1993-04-01 UA UA94095853A patent/UA29437C2/uk unknown
- 1993-04-01 SK SK1177-94A patent/SK281258B6/sk not_active IP Right Cessation
- 1993-04-01 ES ES93907975T patent/ES2115055T3/es not_active Expired - Lifetime
- 1993-04-01 PL PL93305404A patent/PL180014B1/pl unknown
- 1993-04-01 RU RU94042465A patent/RU2128650C1/ru active
- 1993-04-01 SG SG1996005610A patent/SG47948A1/en unknown
- 1993-04-01 JP JP05517251A patent/JP3120810B2/ja not_active Expired - Lifetime
- 1993-04-01 DK DK93907975T patent/DK0633879T3/da active
- 1993-04-01 KR KR1019940703465A patent/KR100259567B1/ko not_active IP Right Cessation
- 1993-04-02 MX MX9301935A patent/MX9301935A/es unknown
- 1993-04-02 MY MYPI93000602A patent/MY110149A/en unknown
- 1993-04-02 ZA ZA932415A patent/ZA932415B/xx unknown
- 1993-04-02 IL IL105276A patent/IL105276A/xx not_active IP Right Cessation
- 1993-04-02 MA MA23157A patent/MA22866A1/fr unknown
- 1993-04-03 DZ DZ930038A patent/DZ1677A1/fr active
- 1993-04-03 CN CN93104534A patent/CN1044367C/zh not_active Expired - Lifetime
- 1993-04-30 TW TW082103364A patent/TW282455B/zh not_active IP Right Cessation
1994
- 1994-09-30 FI FI944546A patent/FI105025B/fi not_active IP Right Cessation
- 1994-09-30 NO NO943645A patent/NO302170B1/no not_active IP Right Cessation
1995
- 1995-06-13 HU HU95P/P00192P patent/HU211529A9/hu unknown
1996
- 1996-12-18 AU AU75456/96A patent/AU705419B2/en not_active Expired
1998
- 1998-08-21 HK HK98110056A patent/HK1009331A1/xx not_active IP Right Cessation
2000
- 2000-05-30 JP JP2000159319A patent/JP2000319259A/ja active Pending

Also Published As

Publication number	Publication date
ATE163925T1 (de)	1998-03-15
HK1009331A1 (en)	1999-05-28
NO943645L (no)	1994-11-16
CN1044367C (zh)	1999-07-28
NO302170B1 (no)	1998-02-02
FI105025B (fi)	2000-05-31
DE69317411T2 (de)	1998-07-30
ZA932415B (en)	1993-10-22
RU2128650C1 (ru)	1999-04-10
DE69317411D1 (de)	1998-04-16
CZ240994A3 (en)	1995-12-13
AU7545696A (en)	1997-02-13
DK0633879T3 (da)	1998-09-28
SK117794A3 (en)	1995-05-10
MX9301935A (es)	1994-08-31
IL105276A (en)	1997-06-10
CZ288519B6 (cs)	2001-07-11
MA22866A1 (fr)	1993-12-31
FI944546A (fi)	1994-09-30
EP0633879B1 (en)	1998-03-11
EP0633879A1 (en)	1995-01-18
KR100259567B1 (ko)	2000-07-01
NZ251384A (en)	1996-10-28
SG47948A1 (en)	1998-04-17
RU94042465A (ru)	1996-07-20
PL180014B1 (pl)	2000-11-30
JPH07505385A (ja)	1995-06-15
TW282455B (zh)	1996-08-01
JP2000319259A (ja)	2000-11-21
IL105276A0 (en)	1993-08-18
JP3120810B2 (ja)	2000-12-25
AU3897693A (en)	1993-11-08
UA29437C2 (uk)	2000-11-15
AU705419B2 (en)	1999-05-20
FI944546A0 (fi)	1994-09-30
CA2133427A1 (en)	1993-10-14
CA2133427C (en)	2003-06-10
CN1081669A (zh)	1994-02-09
DZ1677A1 (fr)	2002-02-17
WO1993020052A1 (en)	1993-10-14
HU211529A9 (en)	1995-11-28
MY110149A (en)	1998-02-28
NO943645D0 (no)	1994-09-30
ES2115055T3 (es)	1998-06-16

Publication	Publication Date	Title
DE60209504T2 (de)	2006-10-12	Carbocyclische hydrazino-hemmer von kupferhaltigen aminoxidasen
DE69813896T2 (de)	2003-11-06	Alpha-aminoamidderivate die als analgetische mittel nützlich sind
SK281258B6 (sk)	2001-01-18	(s)-alfa-2-pyridínetánamín, farmaceutická kompozícia s jeho obsahom a jeho použitie
DE69230498T2 (de)	2000-07-27	2-Pyrazinylethylamin-Derivate und ihre Verwendung als Arzneimittel.
JP3023987B2 (ja)	2000-03-21	（Ｓ）−α−フェニル−２−ピリジンエタンアミン（Ｓ）−マレートおよび医薬としてのその使用
US5455259A (en)	1995-10-03	Compounds for the treatment of neurodegenerative disorders
AU639722B2 (en)	1993-08-05	Use of arylalkylamides in the treatment of neurodegenerative diseases
JP3023988B2 (ja)	2000-03-21	（Ｓ）−α−フェニル−２−ピリジンエタンアミンベンゾエートおよび医薬としてのその使用
EP1596852B1 (de)	2009-05-27	Arzneimittel enthaltend substituierte 2-heteroaryl-aminoessigsäure-verbindungen
EP1596856A2 (de)	2005-11-23	Arzneimittel enthaltend substituierte 2-aryl-aminoessigs ure -verbindungen und/oder substituierte 2-heteroaryl-aminoessigsäure-verbindungen
DE10045831A1 (de)	2002-04-04	Thio-Aminosäuren

Legal Events

Date	Code	Title	Description
2013-06-03	MK4A	Patent expired	Expiry date: 20130401